Back    Zoom +    Zoom -
<H Shrs>HSI Adds 99 Pts as MEITUAN-W Gains 2%+; Pharma Boom
Recommend
94
Positive
160
Negative
57
The HSI inched up 99 points or 0.4% to close at 23,381. The HSCEI lifted 32 points or 0.4% to close at 8,469. The HSTECH added 24 points or 0.5% to close at 5,182. Total market turnover for the day amounted to $203.268 billion.

MEITUAN-W (03690.HK) reported a 46.2% YoY hike in 1Q non-IFRS adjusted profit, beating expectations, but warned of a YoY plunge in core local commerce operating profit for 2Q. MEITUAN-W once cratered 5.5%, and closed up 2.1% at $132.1. JD-SW (09618.HK) dropped 1% to $128.3, while BABA-W (09988.HK) picked up 0.9% to $118. The meeting of the State Council's Anti-Monopoly and Anti-Unfair Competition Committee Expert Advisory Group was recently held in Beijing to address 'involutionary' competition.

Pharma elevated. GENSCRIPT BIO (01548.HK), INNOVENT BIO (01801.HK), CSPC PHARMA (01093.HK), LUYE PHARMA (02186.HK) and PHARMARON (03759.HK) advanced 5.3-6.5%, while SINO BIOPHARM (01177.HK) and HANSOH PHARMA (03692.HK) leaped 4.7 and 3.7%. Listed IPO HENGRUI PHARMA (01276.HK) climbed 2.2%.
AAStocks Financial News
Website: www.aastocks.com